Back to search
FDAFDA · Food and drugs·Recall number Z-0325-2027

CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model: SGP010

Published November 11, 2026 · Recall initiated: September 18, 2026

Summary

FDA records medical device Class II recall Z-0325-2027, published November 11, 2026 and initiated September 18, 2026. Recalling firm: Artivion, Inc; Status: Ongoing; Reported quantity: 1; Lot: Serial/Donor Number: 12617554/177871, UDI-DI: 00877234000478, Shipped: 22May2024, Implanted: 05June2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of long-term in vivo data, the possibility of premature graft dysfunction cannot be excluded.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Artivion, Inc
Distributor
US Nationwide distribution in the state of IL.
Lot
Serial/Donor Number: 12617554/177871, UDI-DI: 00877234000478, Shipped: 22May2024, Implanted: 05June2024
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model: SGP010 recalled?

Yes. FDA published recall Z-0325-2027 on November 11, 2026. Reported hazard: A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of long-term in vivo data, the possibility of premature graft dysfunction cannot be excluded.

What should I do if I have this product?

Voluntary: Firm initiated